“Overdose deaths could have been prevented if more people had access to methadone”: An Interview with Dr. Jeff Singer
We talked with surgeon Dr. Jeff Singer, a senior fellow at the Cato Institute, who says that industry claims about the risks of expanding access to methadone for opioid use disorder don’t add up. Here, Dr. Singer makes the case that methadone diversion is largely a symptom of poor access to this lifesaving medication.
What the…? Safer From Harm on Methadone
Methadone is a “gold standard” treatment for opioid use disorder (OUD). But it is over-regulated, stigmatized, and out of reach for many Americans. We talk to Stacey McKenna, R Street’s Resident Senior Fellow in Integrated Harm Reduction, to understand how methadone works, identify existing barriers, and learn what is being done to expand access.
What the…? Safer From Harm on Why Fentanyl is in Stuff
A friend recently asked me, “Why are drug traffickers putting fentanyl in fake prescription pills? Why would they sell a deadly ingredient to their customers?”
The Western War On Vaping Is Harming Public Health
E-cigarettes are widely recognized as a useful tool for reduced usage of traditional combustible tobacco products.
Study Claiming SSPs Increase Overdoses Overlooks Nuances of Real-World Drug Environments
Decades of data support the role of SSPs in reducing the spread of infectious disease and indicate that they do not encourage drug use, but rather recovery.
Harm Reduction 101: Five Harm Reduction Myths
Harm Reduction 101: Five Harm Reduction Myths
New York Post opioid coverage is divisive, fear-mongering tabloid fodder
New York Post opioid coverage is divisive, fear-mongering tabloid fodder
The Latest on Harm Reduction
The Safer from Harm blog features analysis, interviews, news, and more from across the spectrum about public health and harm reduction.
Newest posts will appear first. Sign up for our newsletter to receive these straight in your inbox and learn what our coalition is up to.